In vivo pharmacological actions of F 11356, a novel high efficacy anti-migraine 5-HT1B/D receptor agonist.

被引：0
|
作者：
John, GW [1 ]
Verscheure, Y [1 ]
Infanti, F [1 ]
Bel, L [1 ]
Perez, M [1 ]
Halazy, S [1 ]
Chopin, P [1 ]
Marien, M [1 ]
Colpaert, FC [1 ]
机构：
[1] Ctr Rech Pierre Fabre, F-81106 Castres, France
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1998年 / 358卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P5261
引用
收藏
页码：R523 / R523
页数：1
相关论文
共 50 条
  • [21] Targeting the 5-HT1B/1D and 5-HT1F receptors for acute migraine treatment
    Huang, Pin-Chung
    Yang, Fu-Chi
    Chang, Ching-Mao
    Yang, Chun-Pai
    UPDATE ON EMERGING TREATMENTS FOR MIGRAINE, 2020, 255 : 99 - 121
  • [22] Participation of 5-HT1B receptors in the inhibitory actions of serotonin on masculine sexual behaviour of mice:: pharmacological analysis in 5-HT1B receptor knockout mice
    Rodríguez-Manzo, G
    López-Rubalcava, C
    Hen, R
    Fernández-Guasti, A
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136 (08) : 1127 - 1134
  • [23] F 11356, a novel 5HT derivative with unique high intrinsic activity at 5HT1B/1D receptors in models relevant to migraine.
    John, GW
    Pauwels, PJ
    Perez, M
    Halazy, S
    Le Grand, B
    Verscheure, Y
    Valentin, JP
    Palmier, C
    Wurch, T
    Chopin, P
    Marien, M
    Colpaert, FC
    CEPHALALGIA, 1999, 19 (04) : 404 - 404
  • [24] Preclinical studies characterizing the anti-migraine and cardiovascular effects of the selective 5-HT1D receptor agonist PNU-142633
    McCall, RB
    Huff, R
    Chio, CL
    TenBrink, R
    Bergh, CL
    Ennis, MD
    Ghazal, NB
    Hoffman, RL
    Meisheri, K
    Higdon, NR
    Hall, E
    CEPHALALGIA, 2002, 22 (10) : 799 - 806
  • [25] The Effects of 5-HT1B/1D Receptor Agonist on Cortical Spreading Depression
    Supronsinchai, W.
    Hoffmann, J.
    Goadsby, P. J.
    HEADACHE, 2011, 51 : 51 - 51
  • [26] Vascular effects of 5-HT1B/1D-receptor agonists in migraine patients
    Van Bortel, LMAB
    de Hoon, JNJM
    Troost, J
    Struijker-Boudier, HAJ
    JOURNAL OF HYPERTENSION, 2000, 18 : S192 - S192
  • [27] A review of rizatriptan, a quick and consistent 5-HT1B/1D agonist for the acute treatment of migraine
    Pascual, J
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (03) : 669 - 677
  • [28] Safety and tolerability of the novel 5-HT1B/1D agonist rizatriptan in migraineurs
    Dahlöf, C
    HEADACHE, 1999, 39 : S16 - S18
  • [29] MOLECULAR-CLONING AND FUNCTIONAL-CHARACTERIZATION OF A HUMAN 5-HT1B SEROTONIN RECEPTOR - A HOMOLOG OF THE RAT 5-HT1B RECEPTOR WITH 5-HT1D-LIKE PHARMACOLOGICAL SPECIFICITY
    HAMBLIN, MW
    METCALF, MA
    MCGUFFIN, RW
    KARPELLS, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (02) : 752 - 759
  • [30] Vascular effects of 5-HT1B/1D-receptor agonists in patients with migraine headaches
    de Hoon, JNJM
    Willigers, JM
    Troost, J
    Struijker-Boudier, HAJ
    Van Bortel, LMAB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (04) : 418 - 426
12345